Samuel Forrester Hunter, MD, PhD
1 clinical trials · Sponsor
◉ Watch Samuel Forrester Hunter, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects (NCT01624714) | Samuel Forrester Hunter, MD, PhD | 2012-09-01 |
Track Samuel Forrester Hunter, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.